CD8A and neoplasm: On the other hand, the variable changes seen in immunotherapy treated groups could be attributed to a similar effect coupled to immunological response or counteracted by a decreased tumor burden between timepoints, as seen on CD8-targeted PET imaging of responding tumors undergoing immunotherapy 50.